Hyaluronan expression in differentiated thyroid carcinoma

Journal of Pathology

Volumn 196, Issue 2, 2002, Pages 180-185

  Bhm, Jan ^a   Niskanen, Leo ^a   Tammi, Raija ^a,b   Tammi, Markku ^a,b   Eskelinen, Matti ^a,b,c   Pirinen, Risto ^a,b,c   Hollmen, Sinikka ^a,b,c   Alhava, Esko ^a,b,c   Kosma, Veli Matti ^a,b,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Differentiated thyroid carcinoma; Hyaluronan; Mortality; Prognosis

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID; POLYSACCHARIDE;

ADULT; AGE; ARTICLE; BIOTINYLATION; CANCER CELL CULTURE; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXON; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; CHI-SQUARE DISTRIBUTION; CHILD; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; STROMAL CELLS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036153909     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1032     Document Type: Article

References (30)

1. Hyaluronan
2. Hyaluronan is not just a goo!
3. Hyaluronate-cell interactions and growth factor regulation of hyaluronate synthesis during limb development
4. Tumor-associated hyaluronan. Providing an extra-cellular matrix that facilitates invasion
5. Endothelial cell adhesion molecule GP116 is a new CD44 variant (Ex14-v10) involved in mediating hyaluronic acid-induced functions
6. The role of hyaluronan in tumour neovascularization
7. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
8. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer
9. Prognostic value of hyaluronan expression in non-small cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma
10. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer
11. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma
12. Hyaluronan metabolism in skin
13. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers
14. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma
15. Irregular expression of hyaluronan and its CD44 receptor is associated with metastatic phenotype in laryngeal squamous cell carcinoma
16. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
17. Expression of fibroblast growth factors in thyroid cancer
18. Immunocytochemical localisation of tumor necrosis factor alpha in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders
19. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients
20. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades
21. Follicular thyroid cancer
22. Hyaluronan and cell locomotion
23. Angiogenesis and tumor metastasis
24. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
25. Co-localization of hyaluronan and hyaluronectin in normal and neoplastic breast tissues
26. Hyaluronan: Its nature, distribution, functions and turnover
27. Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Introduction of cleavage of L-selectin via CD16
28. Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability
29. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate